A peptidomimetic inhibitor of matrix metalloproteinases containing a tetherable linker group
β Scribed by Yang Cao; Tristan I. Croll; Simone C. Rizzi; Gary K. Shooter; Helen Edwards; Kathleen Finlayson; Zee Upton; Tim R. Dargaville
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 289 KB
- Volume
- 96A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Successful wound repair and normal turnover of the extracellular matrix relies on a balance between matrix metalloproteinases (MMPs) and their natural tissue inhibitor of metalloproteinases (TIMPs). When overexpression of MMPs and abnormally high levels of activation or low expression of TIMPs are encountered, excessive degradation of connective tissue and the formation of chronic ulcers can occur. One strategy to rebalance MMPs and TIMPs is to use inhibitors. We have designed a synthetic pseudopeptide inhibitor with an amine linker group based on a known highβaffinity peptidomimetic MMP inhibitor and have demonstrated inhibition of MMPβ1, β2, β3, and β9 activity in standard solutions. The inhibitor was also tethered to a polyethylene glycol hydrogel using a facile reaction between the linker unit on the inhibitor and the hydrogel precursors. After tethering, we observed inhibition of the MMPs although there was an increase in the IC~50~s that was attributed to poor diffusion of the MMPs into the hydrogels, reduced activity of the tethered inhibitor, or incomplete incorporation of the inhibitor into the hydrogels. When the tethered inhibitors were tested against chronic wound fluid, we observed partial inhibition in proteolytic activity suggesting this approach may prove useful in rebalancing MMPs within chronic wounds. Β© 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 2011.
π SIMILAR VOLUMES
The matrix metalloproteinases are a large group of zinc-containing proteases with a central role in the degradation of all types of extracellular matrix. Increased matrix degradation is a characteristic feature of several disease processes, most notably tumour invasion; it is now widely recognized t
## Background: In the current study, the authors investigated the effects of synthetic low molecular weight inhibitors of matrix metalloproteinases (mmps) on the expression and activation of mmp-2 in a three-dimensional tissue system. ## Methods: Rabbit periosteal explants were cultured with or w
## Abstract The __in vivo__ disposition and antitumor efficacy of a newly developed phosphinic matrix metalloproteinase inhibitor (RXP03) were examined. RXP03 potently inhibits MMPβ11, MMPβ8 and MMPβ13, but not MMPβ1 and MMPβ7. Twentyβfour hours after i.p. injection into mice, most of the RXP03 was
Membrane type-1 matrix metalloproteinase (MT1-MMP) and alphavbeta3 integrin have been directly implicated in tumor cell dissemination and metastasis. We have demonstrated that in the case of breast carcinoma MCF7 cells co-expressing MT1-MMP and alphavbeta3 integrin, the proteinase processes the pro-